Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Moreira, Rodrigo Oliveira
Lopes Assis Coelho, Raquel C.
Text and Data Mining valid from 2018-04-03
20 December 2017
21 March 2018
3 April 2018